bf/NASDAQ:CVAC_icon.jpeg

COM:CUREVAC

CureVac

  • Stock

Last Close

2.71

05/11 21:00

Market Cap

697.59M

Beta: -

Volume Today

752.87K

Avg: -

  • locale

    deGermany
  • market

    STOCKS
  • industry

    Biopharmaceuticals
  • website

    curevac.com
  • crunchbase

    curevac
  • linkedin

    curevac
  • founding date

    Jan 01, 2000
  • ipo date

    Aug 14, 2020

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical tr...Show More

peer of

competitor of